Edition:
United States

GNI Group Ltd (2160.T)

2160.T on Tokyo Stock Exchange

497JPY
2:00am EDT
Change (% chg)

¥-5 (-1.00%)
Prev Close
¥502
Open
¥501
Day's High
¥505
Day's Low
¥490
Volume
2,785,000
Avg. Vol
9,225,205
52-wk High
¥938
52-wk Low
¥142

2160.T

Chart for 2160.T

About

GNI Group Ltd. is a Japan-based company engaged in the drug discovery activities that utilize biotechnologies. The Company is engaged in the development of therapeutic agents for diseases that have many sufferers in Asian countries such as Japan and China, as well as clinical trial and bio-verification test businesses. The... (more)
No analyst recommendations are available for 2160.T.

Overall

Beta: 1.43
Market Cap(Mil.): ¥67,475.74
Shares Outstanding(Mil.): 134.41
Dividend: --
Yield (%): --

Financials

  2160.T Industry Sector
P/E (TTM): -- 78.89 32.56
EPS (TTM): -0.96 -- --
ROI: -0.43 2.83 14.89
ROE: -1.77 5.09 16.13

BRIEF-GNI Group says exercise of options

* Says 4,082 units of its 40th series options were exercised to 4.1 million shares of its common stock, from July 3 to July 18

Jul 18 2017

BRIEF- GNI Group unit GNI USA to sell stake in IriSys for $3.8 mln and GNI Group to acquire stake in GNI-EPS (HONG KONG) HOLDINGS for $4.2 mln

* Says its wholly owned unit GNI USA, Inc will sell 242,029 voting rights in IriSys, LLC to EPS Americas, Corp., for $3.8 million (425.2 million yen), on July 31, and will cut voting power in IriSys, LLC to 15 percent from 35 percent

Jun 30 2017

BRIEF-GNI Group says exercise of options

* Says 2,102 units of its 40th series options were exercised to 2,102,000 shares of its common stock from June 15 to June 20

Jun 20 2017

BRIEF-GNI Group says exercise of options

* Says 5,909 units of its 40th series options were exercised to 5.9 million shares of its common stock, from June 13 to June 14

Jun 14 2017

BRIEF- GNI Group announces exercise of options

* Says 2,196 units of its 40th series options were exercised to 2.2 million shares of its common stock from June 5 to June 12

Jun 12 2017

BRIEF- GNI Group announces exercise of options

* Says 2,055 units of its 40th series options were exercised to 2.1 million shares of its common stock on June 1 and June 2

Jun 02 2017

BRIEF-GNI Group announces exercise of options

* Says 2,536 of its 40th series options were exercised to 2.5 million shares, during period from May 9 to May 25

May 25 2017

CORRECTED-OFFICIAL-BRIEF-GNI Group to acquire Berkeley Advanced Biomaterials through GNI USA(April 18)

* Says it will acquire 70 percent voting power of a new unit of Berkeley Advanced Biomaterials, Inc., for $59.7 million (6.51 billion yen), through GNI USA, Inc.

Apr 19 2017

Earnings vs. Estimates